129 related articles for article (PubMed ID: 7259838)
1. The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation.
Hoppe RT; Kushlan P; Kaplan HS; Rosenberg SA; Brown BW
Blood; 1981 Sep; 58(3):592-8. PubMed ID: 7259838
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in advanced non-Hodgkin's lymphomas.
Portlock CS; Rosenberg SA
Cancer; 1976 Mar; 37(3):1275-82. PubMed ID: 1260652
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
[TBL] [Abstract][Full Text] [Related]
4. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial.
Portlock CS; Rosenberg SA; Glatstein E; Kaplan HS
Blood; 1976 May; 47(5):747-56. PubMed ID: 769864
[TBL] [Abstract][Full Text] [Related]
6. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
8. Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy.
Glick JH; Barnes JM; Ezdinli EZ; Berard CW; Orlow EL; Bennett JM
Blood; 1981 Nov; 58(5):920-5. PubMed ID: 7028181
[TBL] [Abstract][Full Text] [Related]
9. The place of radiation therapy in the treatment of non-Hodgkin's lymphomas.
Hellman S; Chaffey JT; Rosenthal DS; Moloney WC; Canellos GP; Skarin AT
Cancer; 1977 Feb; 39(2 Suppl):843-51. PubMed ID: 65208
[TBL] [Abstract][Full Text] [Related]
10. Prednimustine v cyclophosphamide-vincristine-prednisolone in the treatment of non-Hodgkin's lymphoma with favorable histopathology: results of a national cancer care program in Sweden.
Cavallin-Ståhl E; Möller TR
Semin Oncol; 1986 Mar; 13(1 Suppl 1):19-22. PubMed ID: 3952518
[TBL] [Abstract][Full Text] [Related]
11. Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin's lymphomas.
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Med Pediatr Oncol; 1977; 3(1):41-51. PubMed ID: 320448
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in the management of stage III/IV grade 1 non-Hodgkin's lymphomas (Report no 17).
Hayhoe FG
Clin Radiol; 1981 Sep; 32(5):547-52. PubMed ID: 7023798
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.
Bonadonna G; De Lena M; Lattuada A; Milani F; Monfardini S; Beretta G
Br J Cancer Suppl; 1975 Mar; 2():481-8. PubMed ID: 52367
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in non-Hodgkin's lymphoma.
Tubiana M; Carde P; Burgers JM; Cosset JM; Van Glabbeke M; Somers R
Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):503-14. PubMed ID: 3516950
[TBL] [Abstract][Full Text] [Related]
15. Histologic conversion in the non-Hodgkin's lymphomas.
Acker B; Hoppe RT; Colby TV; Cox RS; Kaplan HS; Rosenberg SA
J Clin Oncol; 1983 Jan; 1(1):11-6. PubMed ID: 6366124
[TBL] [Abstract][Full Text] [Related]
16. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
17. Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
Hagenbeek A; Eghbali H; Monfardini S; Vitolo U; Hoskin PJ; de Wolf-Peeters C; MacLennan K; Staab-Renner E; Kalmus J; Schott A; Teodorovic I; Negrouk A; van Glabbeke M; Marcus R
J Clin Oncol; 2006 Apr; 24(10):1590-6. PubMed ID: 16575010
[TBL] [Abstract][Full Text] [Related]
18. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
Bonadonna G; Monfardini S; Villa E
Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
[TBL] [Abstract][Full Text] [Related]
19. Results of combination chemotherapy of non-Hodgkin's lymphoma.
Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
[TBL] [Abstract][Full Text] [Related]
20. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
Nissen NI; Pajak T; Glidewell O; Blom H; Flaherty M; Hayes D; McIntyre R; Holland JF
Cancer Treat Rep; 1977 Sep; 61(6):1097-107. PubMed ID: 71208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
